The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

Biogen BIIB and partner Eisai announced that the European Commission (EC) has granted marketing authorization to Leqembi ...

CHMP reversed its initial recommendation for the EC to not authorize the drug due to the risk of side effects like ARIA.

Eisai and Biogen can finally put their European regulatory uncertainty surrounding Alzheimer's disease medicine Leqembi ...

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA). Vi ...

Anavex could secure conditional approval for blarcamesine, though longer trials may be needed. Check out why AVXL stock is a ...

AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. See ...

BRUSSELS, April 1 (Reuters) - The European Commission said on Tuesday it will propose expanding the role of EU law enforcement cooperation agency Europol and boosting law enforcement access to ...

The European Space Agency has kicked off a competition to support the development of new launch vehicles and boost Europe's access to space. The agency issued the call for proposals for the ...

To develop new antibiotics, Belgium will support European initiatives in this area," Verougstrate remarked. Reforms are also underway at the Federal Agency for Medicines and Health Products (AFMPS ...